Nestlé makes Atrium move
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Nestlé has signalled its intention to become a force in consumer healthcare by acquiring Canadian supplements specialist Atrium Innovations for US$2.3 billion (€1.95 billion) from a group of investors led by Permira Funds. Subject to regulatory approval, the transaction is expected to close in the first quarter of 2018.
You may also be interested in...
Nestle Harvests Plant-Based Protein Firm Orgain As Latest US Nutrition Business Investment
Nestle Health Science has expanded its nutritional footprint steadily since 2017 but investing in Orgain, with option to fully acquire in 2024 brings its first business working exclusively with plant-based ingredients.
Nestle's Atrium Adds LivingMatrix As New Cog In Personalized Health Strategy
Atrium expects to scale its nutrition personalization services by integrating LivingMatrix with its PureGenomics platform, which combines educational tools, protocols and core products with a practitioner website application to help identify and address single nucleotide polymorphisms.
Nestlé Developing Microbiome-Based Supplements with Dutch Partner
Nestlé Health Science is putting its financial weight behind the